RWD261 Myasthenia Gravis Healthcare Resource Use and Cost of Therapy In Australia

Hansoo Kim; Leonard Lee; Jeremy Welton; Josh Byrnes

doi:10.1016/j.vhri.2025.101411

RWD261 Myasthenia Gravis Healthcare Resource Use and Cost of Therapy In Australia

Hansoo Kim
, Leonard Lee
, Jeremy Welton
, Josh Byrnes

Research output: Contribution to journal › Meeting Abstract › Research › peer-review

Abstract

The identification of myasthenia gravis (MG) patients in administrative health databases is challenging due to the disease rarity, presentation heterogeneity, and limitations of available diagnostic codes. This study aims to to establish a retrospective cohort of patients with MG from a national database to estimate healthcare resource utilisation (HCRU) and associated costs.

Original language	English
Pages (from-to)	S23-S23
Number of pages	1
Journal	Value in Health Regional Issues
Volume	49
Issue number	Supplement 1
DOIs	https://doi.org/10.1016/j.vhri.2025.101411
Publication status	Published - Oct 2025
Externally published	Yes
Event	ISPOR Real-World Evidence Summit 2025: Through the Lens of Asia Pacific - Tokyo, Japan Duration: 28 Sept 2025 → 30 Sept 2025 https://www.ispor.org/heor-resources/news-top/news/view/2025/09/09/ispor-real-world-evidence-summit-28-30-september-2025---tokyo--japan

Access to Document

10.1016/j.vhri.2025.101411Licence: CC BY-NC-ND

Cite this

@article{c54cd52d0882479186c7f46b563098e2,

title = "RWD261 Myasthenia Gravis Healthcare Resource Use and Cost of Therapy In Australia",

abstract = "The identification of myasthenia gravis (MG) patients in administrative health databases is challenging due to the disease rarity, presentation heterogeneity, and limitations of available diagnostic codes. This study aims to to establish a retrospective cohort of patients with MG from a national database to estimate healthcare resource utilisation (HCRU) and associated costs.",

author = "Hansoo Kim and Leonard Lee and Jeremy Welton and Josh Byrnes",

year = "2025",

month = oct,

doi = "10.1016/j.vhri.2025.101411",

language = "English",

volume = "49",

pages = "S23--S23",

journal = "Value in Health Regional Issues",

issn = "2212-1102",

publisher = "Elsevier",

number = "Supplement 1",

note = "ISPOR Real-World Evidence Summit 2025: Through the Lens of Asia Pacific ; Conference date: 28-09-2025 Through 30-09-2025",

url = "https://www.ispor.org/heor-resources/news-top/news/view/2025/09/09/ispor-real-world-evidence-summit-28-30-september-2025---tokyo--japan",

}

TY - JOUR

T1 - RWD261 Myasthenia Gravis Healthcare Resource Use and Cost of Therapy In Australia

AU - Kim, Hansoo

AU - Lee, Leonard

AU - Welton, Jeremy

AU - Byrnes, Josh

PY - 2025/10

Y1 - 2025/10

N2 - The identification of myasthenia gravis (MG) patients in administrative health databases is challenging due to the disease rarity, presentation heterogeneity, and limitations of available diagnostic codes. This study aims to to establish a retrospective cohort of patients with MG from a national database to estimate healthcare resource utilisation (HCRU) and associated costs.

AB - The identification of myasthenia gravis (MG) patients in administrative health databases is challenging due to the disease rarity, presentation heterogeneity, and limitations of available diagnostic codes. This study aims to to establish a retrospective cohort of patients with MG from a national database to estimate healthcare resource utilisation (HCRU) and associated costs.

U2 - 10.1016/j.vhri.2025.101411

DO - 10.1016/j.vhri.2025.101411

M3 - Meeting Abstract

SN - 2212-1102

VL - 49

SP - S23-S23

JO - Value in Health Regional Issues

JF - Value in Health Regional Issues

IS - Supplement 1

T2 - ISPOR Real-World Evidence Summit 2025: Through the Lens of Asia Pacific

Y2 - 28 September 2025 through 30 September 2025

ER -

RWD261 Myasthenia Gravis Healthcare Resource Use and Cost of Therapy In Australia

Abstract

Access to Document

Fingerprint

Cite this